Brii Biosciences Limited (7SS) — Working Capital to Net Assets Ratio
Brii Biosciences Limited (7SS) has a Working Capital to Net Assets ratio of 83.1% as of December 2025. Working capital of €1.93 Billion (current assets of €1.96 Billion minus current liabilities of €32.31 Million) is measured against net assets of €2.32 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Brii Biosciences Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Brii Biosciences Limited Working Capital to Net Assets (2020–2025)
This chart shows how Brii Biosciences Limited's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 83.1%, reflecting working capital of €1.93 Billion against net assets of €2.32 Billion EUR. For the complete balance sheet picture, see Brii Biosciences Limited (7SS) total assets.
Annual Working Capital to Net Assets for Brii Biosciences Limited (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Brii Biosciences Limited from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Brii Biosciences Limited to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.1% | €1.93 Billion | €2.32 Billion | €1.96 Billion | €32.31 Million | ▼ -6.6 pp |
| 2024 | 89.7% | €2.34 Billion | €2.61 Billion | €2.41 Billion | €77.42 Million | ▲ +3.2 pp |
| 2023 | 86.5% | €2.66 Billion | €3.07 Billion | €2.78 Billion | €125.87 Million | ▼ -3.7 pp |
| 2022 | 90.2% | €2.85 Billion | €3.16 Billion | €3.08 Billion | €229.11 Million | ▼ -4.4 pp |
| 2021 | 94.6% | €3.13 Billion | €3.31 Billion | €3.41 Billion | €280.71 Million | ▲ +124.3 pp |
| 2020 | -29.7% | €517.61 Million | €-1.74 Billion | €1.09 Billion | €575.24 Million | — |